Evans blue dye-enhanced capillary-resolution photoacoustic microscopy in vivo by Yao, Junjie et al.
E
p
J
K
S
L
W
O
D
O
S
1
I
c
c
g
i
o
w
s
s
s
g
b
b
s
s
t
p
c
c
m
p
o
d
b
i
o
f
e
A
D
B
E
Journal of Biomedical Optics 145, 054049 September/October 2009
J
Downloaded Frovans blue dye-enhanced capillary-resolution
hotoacoustic microscopy in vivo
unjie Yao
onstantin Maslov
ong Hu
ihong V. Wang
ashington University in St. Louis
ptical Imaging Laboratory
epartment of Biomedical Engineering
ne Brookings Drive
t. Louis, Missouri 63130
Abstract. Complete and continuous imaging of microvascular net-
works is crucial for a wide variety of biomedical applications. Pho-
toacoustic tomography can provide high resolution microvascular im-
aging using hemoglobin within red blood cells RBCs as an
endogenic contrast agent. However, intermittent RBC flow in capillar-
ies results in discontinuous and fragmentary capillary images. To over-
come this problem, we use Evans blue EB dye as a contrast agent for
in vivo photoacoustic imaging. EB has strong optical absorption and
distributes uniformly in the blood stream by chemically binding to
albumin. With the help of EB, complete and continuous microvascu-
lar networks—especially capillaries—are imaged. The diffusion dy-
namics of EB leaving the blood stream and the clearance dynamics of
the EB-albumin complex are also quantitatively investigated. © 2009
Society of Photo-Optical Instrumentation Engineers. DOI: 10.1117/1.3251044
Keywords: photoacoustic imaging; Evans blue dye; diffusion dynamics; Evans blue-
albumin clearance.
Paper 09184R received May 9, 2009; revised manuscript received Aug. 28, 2009;
accepted for publication Sep. 2, 2009; published online Oct. 26, 2009.Introduction
n the last decade, photoacoustic PA tomography, which
ombines the spatial resolution of ultrasound imaging with the
ontrast of optical absorption in deep biological tissues,1,2 has
ained great attention in biomedical applications.3,4 Ultrasonic
maging yields better spatial resolution in deep tissues than
ptical techniques, because ultrasonic scattering is much
eaker than optical scattering,2 making possible image recon-
truction based on propagated waves rather than energy diffu-
ion. However, pure ultrasonic imaging is insensitive to early
tage tumors and other biochemical properties, such as oxy-
en saturation or concentration of hemoglobin, because it is
ased on the detection of the bulk mechanical properties of
iological tissues. By combining optical imaging with ultra-
ound, PA imaging can achieve both high contrast and high
patial resolution. PA imaging has been used for both struc-
ural and functional imaging of tumor,5 brain cortex
erfusion,6,7 microvascular structure,8 and hemoglobin con-
entration and oxygenation,9 as well as for lymph flow
ytometry.10 Furthermore, it shows potential for blood flow
easurement.11,12 Since the amplitude of the PA signal is pro-
ortional to the absorbed optical energy density i.e., specific
ptical absorption, the PA technique has the advantage of
irectly measuring the absorption spectra in vivo, allowing
etter tissue identification and providing functional
nformation.2,5,9,10 Thus PA imaging is complementary with
ther high resolution optical imaging modalities such as con-
ocal microscopy, two-photon microscopy, and optical coher-
nce tomography, which can provide in vivo imaging within
ddress all correspondence to: Lihong Wang, Dr., Optical Imaging Laboratory,
epartment of Biomedical Engineering, Washington University in St. Louis, One
rookings Dr., St. Louis, MO 63130. Tel: 314-935-6152; Fax: 314-935-7448;
-mail: lhwang@seas.wustl.eduournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usethe optical transport mean free path 1 mm of biological
tissues.13
Previously, an optical-resolution confocal photoacoustic
microscope OR-PAM was described, with a lateral reso-
lution of 5 m, axial resolution of 15 m, and imaging depth
greater than 0.7 mm.8 OR-PAM is a good tool to image blood
vessels at the capillary level. High spatial resolution of OR-
PAM can resolve capillaries smaller than 10 m in diameter14
using hemoglobin within red blood cells RBCs as an en-
dogenic contrast agent.
However, RBC flow in capillaries is discontinuous and
changes greatly over time.15–17 Because RBCs are the only
noticeable optical absorbers in capillaries, it is highly likely
that no absorber is present in a particular voxel during the
laser pulse, which results in discontinuous capillaries in a
RBC-based PA image. To acquire a complete capillary image
and gain information about the capillary’s functional state,18
the use of an exogenic contrast agent is compelling.
In this work we use Evans blue EB dye for this purpose.
EB has strong absorption in visible and near-infrared light,
with a peak at 620 nm. EB is nontoxic and is used in mea-
surement of blood volume,19 lymph node location,20 mi-
crovascular permeability,21,22 blood-retinal barrier
breakdown,23 capillary perfusion,17 and blood plasma flow,15
among other applications. In the blood stream, EB mainly
binds to serum albumin in a reversible manner, so it is uni-
formly distributed in the plasma, maximizing the chance to
get a complete capillary network image. Under normal condi-
tions, the EB-albumin EBA complex is confined to blood
vessels, while the free dye more readily diffuses out into ex-
travascular tissue. The diffused dye is bound to the surround-
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Downloaded Frong tissue proteins, and finally cleared out by either metabo-
ism or excretion.24–27
This work seeks to achieve complete capillary network
maging, to quantitatively investigate the dynamic diffusion of
B out of the circulation system, and to elucidate the dynamic
learance of EBA.
Materials and Methods
.1 Optical-Resolution Confocal Photoacoustic
Microscope System
he OR-PAM system used in this work has been described in
etail previously.8 Briefly, a Nd:YLF laser INNOSLAB,
23 nm, Edgewave, Aachen, Germany pumped a dye laser
CBR-D, Sirah, Karst, Germany used as the irradiation
ource. To cover the wavelength requirement for both RBCs
nd EB, laser dye Pyrro597 peak at 582 nm, tuning range
66 to 611 nm was employed. The 7-ns laser pulse was
assed through a 25-m-diam pinhole and focused by a mi-
roscope objective lens Olympus 4, NA=0.1. The laser
nergy after the objective lens was 100 nJ. Ultrasonic de-
ection was achieved through a spherically focused ultrasonic
ransducer V2012-BC, Panametrics-NDT, Olympus, focal
pot size 27 m with a center frequency of 75 MHz, and a
oundtrip 6-dB bandwidth of 80%, placed confocally with the
ptical objective. The PA signal detected by the ultrasonic
ransducer was amplified, digitized, and saved. The laser
ower was monitored by a reference channel to compensate
or laser power instability. A volumetric image was generated
y recording the time-resolved PA signal A-line at each
orizontal location of the 2-D raster scan.
.2 Animal Preparation
he ears of adult, 6- to 8-week-old nude mice Hsd: Athymic
ude-FoxlNU Harlan Company, Indianapolis, Indiana, body
eight 20 g were used for all in vivo experiments here,
ecause their small thickness allowed us to verify some of the
A results by using a standard bright field optical microscope.
he nude mouse ear model has a well-developed vasculature
nd has been widely used to study tumor angiogenesis and
ther microvascular diseases.28 Before data acquisition, the
nimal was anesthetized by an intraperitoneal injection of
5% ketamine and 15% xylazine 100-l /g body weight.
uring data acquisition, the animal was placed on a warming
ad 37 °C, and its head was held steady with a dental/hard
alate fixture. The animal was kept still by using a breathing
nesthesia system E-Z Anesthesia, Euthanex, Palmer, Penn-
ylvania. After the experiment, the animal recovered natu-
ally and was returned to its cage. All experimental animal
rocedures were carried out in conformity with the laboratory
nimal protocol approved by the Animal Studies Committee
f the School of Medicine at Washington University in Saint
ouis.
.3 Mode of Injection of Evans Blue
6 or 3% EB w/v solution Sigma, Saint Louis, Missouri
as prepared by dilution of the dye in phosphate-buffered
aline PBS, pH 7.5. Before injection, the solution was fil-ournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usetered through a 5-m filter. An intravenous injection of EB
was made to either of the dorsal veins of the tail. The injection
lasted for about 10 to 20 s.
2.4 Spatially Continuous Capillary Imaging Using
Evans Blue as a Contrast Agent
Two irradiation wavelengths 570 and 610 nm were chosen for
RBC imaging and EB imaging, respectively. An area of
22 mm was chosen as the field of interest FOI near the
margin of the nude mouse ear, where the capillary density was
higher. Before the dye injection, control images were acquired
with a scanning step size of 2.5 m at 570 and 610 nm. The
total scanning time for a complete volumetric dataset was
30 min for each wavelength. To get sufficient imaging con-
trast and sensitivity of the capillaries, a relatively high con-
centration of EB in the blood plasma should be reached. Here
0.2 mL of 6% EB solution was injected in a nude mouse
body weight 20 g. The total blood volume of the mouse
was about 1.2 mL.29 Thus the concentration of EB in the
blood stream was 1%, corresponding to an absorption co-
efficient of 1000 cm−1 at 610 nm,30 which is 20 times
higher than that of blood 50 cm−1. Two PA images at
610 nm were acquired, one immediately after the dye injec-
tion and the other 30 min later. Transmission optical micro-
scopic images at 4 magnification were acquired before and
after injection.
2.5 Dynamics of Evans Blue Diffusion Out of the
Blood Stream
EB is removed from the vascular system principally by dif-
fusing into extravascular tissue. At high dye concentrations, in
the first few hours, it is mainly the free EB rather than the
EB-albumin complex that diffuses out. The fixation of the free
EB molecules by tissue proteins causes more dye to leave the
blood to maintain chemical equilibrium, until the tissue pro-
teins become saturated.24–27,31 To better understand the diffu-
sion dynamics, we monitored the dye diffusion over time and
quantified the diffused dye volume in the tissue. Here, a
smaller area of 11 mm was imaged near the margin of the
nude mouse ear, so more datasets could be acquired over time
due to the shorter scanning time of 10 min. Control images
at 570 nm 610 nm were acquired before dye injection. After
0.1 mL of 6% EB solution was injected, the dye molar con-
centration in the plasma was 0.52 mM, which was a high
concentration compared with the combination capability of
albumin.27 Right after injection, serial images at 610 nm were
acquired every 20 min until the dye diffusion was observed to
have reached saturation.
2.6 Dynamics of the Evans Blue Albumin Clearance
At low dye concentrations, EB exists almost exclusively in
the form of EBA.27 EB permeates wherever albumin is
present. Therefore, the clearance dynamics of the EBA may
be used to estimate the albumin metabolic rate in tissue.27 To
better understand the clearance dynamics, in our work the
EBA volume in the tissue was monitored by PA imaging. An
imaging area of 11 mm was chosen on the nude mouse ear,
and control images at 570 and 610 nm were acquired before
dye injection. Then 0.05 mL of 3% EB solution was injectedSeptember/October 2009  Vol. 1452
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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Downloaded Froia the tail vein. Serial images were acquired at 610 nm every
ne or two days, until EBA had almost completely cleared
ut.
.7 Quantitative Data Processing
ll the data processing in this work was based on the volu-
etric datasets. A typical 3-D data cube in this work consists
f 200400400 voxels for a 11-mm scanning area, or
00800800 voxels for a 22-mm scanning area. Each
oxel equals a physical size of 7.52.52.5 m. Hilbert
ransformation was performed along each A-line to extract the
mplitude information. For visualization, a maximum ampli-
ude projection MAP image was obtained by projecting the
aximum value of each A-line onto the transverse scanning
x-y plane. The EB or EBA volume was estimated by count-
ng the voxels.
Results
.1 Spatially Continuous Capillary Imaging Using
Evans Blue as a Contrast Agent
n this study, EB solution 6%, 0.2 mL was injected into the
lood circulation system of the nude mouse. Before dye in-
ection, a PA image was acquired at 570 nm Fig. 1a. He-
oglobin has strong absorption at this wavelength, which
rovided high imaging contrast and a high signal-to-noise ra-
io 40 dB. Veins and arteries larger than 10 m in diam-
ter contained a higher area density of RBCs and appeared
niformly bright. However, smaller capillaries, containing a
ingle of RBCs, looked discontinuous and fragmentary see
he arrows in Fig. 1a. As a control, another image was
cquired at 610 nm Fig. 1b. The signal was very weak due
o the low hemoglobin absorption at 610 nm, which was only
ne-twentieth of that at 570 nm. Right after the dye injection,
ig. 1 EB enhanced photoacoustic imaging of mouse ear microves-
els. PA microvascular image before dye injection acquired at a
70 nm and at b 610 nm. Arrows in a point to the fragmentary
apillaries. c PA image acquired at 610 nm right after EB 6%,
.2 mL injection via tail vein. Arrows in c point to the continuous
apillaries. d PA image acquired at 610 nm acquired 30 min after
njection. Transmission microscopic images of the same area e be-
ore and f after injection. Arrows in d, e, and f point to seba-
eous glands. All the photoacoustic images were scaled to the same
evel of PA signal.ournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usethe microvascular network appeared continuous, as shown in
Fig. 1c. Dense capillaries could be observed, as indicated by
arrows. All the capillaries that appear “broken” in Fig. 1a
became smooth and continuous Video 1. Moreover, the cap-
illary branching points that were invisible in Fig. 1a could
be clearly distinguished. The blood vessels in Fig. 1c appear
somewhat thicker than those in Fig. 1a, which was possibly
because the plasma volume was larger than the RBC volume.
The discernable blood vessel volume in the plasma-based im-
age appeared to be more than 50% greater than that disclosed
in the RBC-based image. The image in Fig. 1d was acquired
at 610 nm 30 min after dye injection. It shows that a consid-
erable amount of EB had diffused out of the blood vessels into
the surrounding tissue but did not diffuse into the sebaceous
glands, which appear as brown patches in the transmission
microscopic images see arrows in Figs. 1d–1f.
3.2 Dynamics of Evans Blue Diffusion Out of the
Blood Stream
As before, control images at 570 and 610 nm were acquired
before dye injection Figs. 2a and 2b. The whole mi-
crovascular network within the field of view showed up with
denser and more continuous capillaries right after the 0.1 mL
Video 1 A volumetric visualization of the images before dye injection
at 570 nm and after dye injection at 610 nm MOV, 0.9 MB. URL:
http://dx.doi.org/10.1117/1.3251044.1.
Fig. 2 Dynamics of EB diffusion out of the blood stream into sur-
rounding tissue. PA images acquired before EB injection at a 570 nm
and at b 610 nm c through g PA images acquired at 610 nm after
EB 6%, 0.1 mL injection at different times. h Partial volume of EB
diffused into surrounding tissue. An exponential recovery model was
used to fit the experiment data. All the photoacoustic images were
scaled to the same level.September/October 2009  Vol. 1453
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Downloaded Frof 6% EB solution was injected Fig. 2c. Sequential images
ere acquired at different time points from 30 to 120 min
Figs. 2d–2g; Video 2. The partial volume of the free EB
olecule diffused into extravascular tissue increased gradu-
lly and reached a plateau after 2 h. If the dye left the blood
essels in a passive diffusion pattern, the extravascular dye
olume could be fitted by an exponential recovery model.32
QTt = Qe1 − exp− kt , 1
here QTt and Qe are the dye volumes at time t and equi-
ibrium, respectively, and k is the dye diffusion rate. The fit
esult shows that EB indeed diffused in a passive pattern Fig.
h. However, EB did not diffuse into the sebaceous glands,
o more and more dark cavities were formed as the diffusion
ent on. Blood vessels were embedded in the diffused dye
nd capillaries became nearly invisible.
.3 Dynamics of Evans Blue Albumin Clearance
o study the EBA clearance in vivo, 0.05 mL of 3% EB so-
ution was injected. Before dye injection, Fig. 3a was ac-
ideo 2 A volumetric visualization of the dynamics of EB diffusion at
10 nm QuickTime,0.9 MB.
URL: http://dx.doi.org/10.1117/1.3251044.2.
ig. 3 Clearance dynamics of EBA. Before EB injection, a was ac-
uired at 610 nm. On 12 to 10 days following EB 3%, 0.05 mL injec-
ion, images b through i were acquired at 610 nm. All the photoa-
oustic images were scaled to the same level.ournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usequired at 610 nm as a control image. Figures 3b–3i were
acquired on different days after dye injection Video 3. The
EBA volume out of the blood vessels was calculated. Quan-
tified clearance is shown in Fig. 4. The EBA volume in the
extravascular tissue reached maximum on day 3 and then de-
creased to the base line by day 10. A two-compartment model
was used to fit the EBA volume in the extravascular tissue.
dQV
dt
= − k1QV,
dQT
dt
= k1QV − k2QT, 2
where QV and QT are the EBA volumes in the blood stream
and extravascular tissue, respectively. k1 is the diffusion rate
of EBA from the blood stream into the extravascular tissue,
and k2 is the clearance rate of EBA in the tissue. The results
were consistent with the standard histological studies of long
term EBA decline.31,33
4 Discussion
In this work, we demonstrate the feasibility of using Evans
blue dye as a contrast agent to enhance in vivo photoacoustic
microvascular imaging. Complete and continuous microvas-
cular networks, especially capillaries, were imaged with the
contrast of EB. And to the best of our knowledge, it is the first
time that PA imaging has been used to study the dynamics of
EB diffusion and EBA clearance.
Video 3 A volumetric visualization of the dynamics of EBA
clearance at 610 nm QuickTime, 0.9 MB.
URL: http://dx.doi.org/10.1117/1.3251044.3.
Fig. 4 Quantitative analysis of EBA clearance. After EB 3%, 0.05 mL
injection, the diffused EBA volume in the surrounding tissue reached
maximum on day 3, and decayed to the baseline by day 10. A two-
compartment model was used to fit the experiment data.September/October 2009  Vol. 1454
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tudy. In a previous study,30 for a pulsed Nd:YAG laser
532 nm, 50 Hz, 14-ns pulse and static 0.3% EB solution,
hotobleaching started after 1-min irradiation with an energy
eposition of 20 mJ /pulse cm2. In our study, the energy pulse
eposition was about 100 mJ /pulse cm2. However, the irra-
iation time was only 7 ns at each imaging position, which is
uch shorter than the reported photobleaching exposure time.
herefore, the influence of photobleaching on the quantitative
tudy can be ignored, and the possibility that the apparent
learance of the dye was caused by photobleaching can be
xcluded.
At high EB concentrations, it is mainly the free dye that
assively diffuses out of the blood vessels over tens of min-
tes. At low EB concentrations, as in most biological
pplications,15,20,22,33,34 it is mainly the EBA that diffuses out
f the blood vessels, and thus it is usually used as an indicator
f the vessel leakage level. Our study was implemented under
aseline conditions, where the blood vessel was leakage resis-
ant for albumin, so relatively high EB concentrations were
sed here to study the dynamics. However, a high contrast PA
mage does not depend on whether free EB dye or EBA
aused dye diffusion into extravascular tissue. The key point
ere is that the potential application of PA imaging combined
ith EB for physiological and pathological studies has been
ell demonstrated. Moreover, to test the imaging sensitivity, a
ommonly used EB injection dose 30-mg /kg body weight
as used Fig. 5, Video 4. The diffused EBA can be clearly
bserved due to the high absorption contrast between the dye-
rotein complex and background tissue, hence the imaging
ensitivity is sufficient for the biological applications.
It is interesting that EB and EBA did not diffuse into the
ebaceous glands, where dark cavities were formed in the PA
mages, possibly caused by the denser structure or the bio-
ig. 5 Imaging sensitivity when a low concentration of EB was used.
he image was acquired at 570 nm on day 2 after 0.02 mL of 0.3% EB
olution was injected. BV is the blood vessel and SG is the sebaceous
land.
ideo 4 A volumetric visualization of the image by using low
oncentration EB QuickTime, 1.4 MB.
URL: http://dx.doi.org/10.1117/1.3251044.4.ournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usechemical properties of the sebaceous glands. The physiologi-
cal characteristics of sebaceous glands have been thoroughly
studied.35 PA imaging facilitated by EB can provide 3-D
structural and functional information of sebaceous glands,
which are very important growth indexes during carcinoma
development.
Acknowledgments
This research is supported by the National Institutes of Health
grants R01 EB000712, R01 NS46214, R01 EB008085, and
U54 CA136398. Author Wang has a financial interest in En-
dra, Incorporated, which, however, did not support this work.
References
1. M. H. Xu and L. H. V. Wang, “Photoacoustic imaging in biomedi-
cine,” Rev. Sci. Instrum. 774, 041101 2006.
2. H. F. Zhang, K. Maslov, G. Stoica, and L. H. V. Wang, “Functional
photoacoustic microscopy for high-resolution and noninvasive in vivo
imaging,” Nat. Biotechnol. 247, 848–851 2006.
3. L. V. Wang, “Tutorial on photoacoustic microscopy and computed
tomography,” IEEE J. Sel. Top. Quantum Electron. 141, 171–179
2008.
4. L. V. Wang, “Prospects of photoacoustic tomography,” Med. Phys.
3512, 5758–5767 2008.
5. M. L. Li, J. T. Oh, X. Y. Xie, G. Ku, W. Wang, C. Li, G. Lungu, G.
Stoica, and L. V. Wang, “Simultaneous molecular and hypoxia imag-
ing of brain tumors in vivo using spectroscopic photoacoustic tomog-
raphy,” Proc. IEEE 963, 481–489 2008.
6. S. H. Yang, D. Xing, Y. Q. Lao, D. W. Yang, L. M. Zeng, L. Z.
Xiang, and W. R. Chen, “Noninvasive monitoring of traumatic brain
injury and post-traumatic rehabilitation with laser-induced photoa-
coustic imaging,” Appl. Phys. Lett. 9024, 243902 2007.
7. X. M. Yang and L. V. Wang, “Monkey brain cortex imaging by pho-
toacoustic tomography,” J. Biomed. Opt. 134, 044009 2008.
8. K. Maslov, H. F. Zhang, S. Hu, and L. V. Wang, “Optical-resolution
photoacoustic microscopy for in vivo imaging of single capillaries,”
Opt. Lett. 339, 929–931 2008.
9. X. D. Wang, X. Y. Xie, G. N. Ku, and L. H. V. Wang, “Noninvasive
imaging of hemoglobin concentration and oxygenation in the rat
brain using high-resolution photoacoustic tomography,” J. Biomed.
Opt. 112, 024015 2006.
10. E. I. Galanzha, E. V. Shashkov, V. V. Tuchin, and V. P. Zharov, “In
vivo multispectral, multiparameter, photoacoustic lymph flow cytom-
etry with natural cell focusing, label-free detection and multicolor
nanoparticle probes,” Cytometry, Part A 73A10, 884–894 2008.
11. H. Fang, K. Maslov, and L. V. Wang, “Photoacoustic doppler flow
measurement in optically scattering media,” Appl. Phys. Lett. 9126,
264103 2007.
12. H. Fang, K. Maslov, and L. V. Wang, “Photoacoustic doppler effect
from flowing small light-absorbing particles,” Phys. Rev. Lett. 9918,
184501 2007.
13. L. V. Wang and H. I. Wu, Biomedical Optics: Principles and Imag-
ing, Wiley-Interscience, Hoboken, New Jersey 2007.
14. S. Takatani and M. D. Graham, “Theoretical analysis of diffuse re-
flectance from a two-layer tissue model,” IEEE Trans. Biomed. Eng.
BME-2612, 656–664 1979.
15. R. Abounader, J. Vogel, and W. Kuschinsky, “Patterns of capillary
plasma perfusion in brains of conscious rats during normocapnia and
hypercapnia,” Circ. Res. 761, 120–126 1995.
16. E. Chaigneau, M. Oheim, E. Audinat, and S. Charpak, “Two-photon
imaging of capillary blood flow in olfactory bulb glomeruli,” Proc.
Natl. Acad. Sci. U.S.A. 10022, 13081–13086 2003.
17. A. Villringer, A. Them, U. Lindauer, K. Einhaupl, and U. Dirnagl,
“Capillary perfusion of the rat-brain cortex—an in vivo confocal mi-
croscopy study,” Circ. Res. 751, 55–62 1994.
18. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other dis-
eases,” Nature (London) 4076801, 249–257 2000.
19. T. D. Poulsen, T. Klausen, J. P. Richalet, I. L. Kanstrup, N. Fogh-
Andersen, and N. V. Olsen, “Plasma volume in acute hypoxia: com-
parison of a carbon monoxide rebreathing method and dye dilution
with Evans’ blue,” Eur. J. Appl. Physiol. 775, 457–461 1998.September/October 2009  Vol. 1455
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
22
2
2
2
2
2
2
2
Yao et al.: Evans blue dye-enhanced capillary-resolution photoacoustic microscopy in vivo
J
Downloaded Fro0. M. I. Harrell, B. M. Iritani, and A. Ruddell, “Lymph node mapping in
the mouse,” J. Immunol. Methods 3321–2, 170–174 2008.
1. W. G. Roberts and G. E. Palade, “Increased microvascular permeabil-
ity and endothelial fenestration induced by vascular endothelial
growth-factor,” J. Cell. Sci. 1086, 2369–2379 1995.
2. C. E. Patterson, R. A. Rhoades, and J. G. N. Garcia, “Evans blue-dye
as a marker of albumin clearance in cultured endothelial monolayer
and isolated lung,” J. Appl. Physiol. 723, 865–873 1992.
3. Q. W. Xu, T. Qaum, and A. P. Adamis, “Sensitive blood-retinal bar-
rier breakdown quantitation using evans blue,” Invest. Ophthalmol.
Visual Sci. 423, 789–794 2001.
4. M. I. Gregersen and R. A. Rawson, “The disappearance of t-1824 and
structurally related dyes from the blood stream,” Am. J. Physiol.
1385, 698–707 1943.
5. R. A. Rawson, “The binding of t-1824 and structurally related diazo
dyes by the plasma proteins,” Am. J. Physiol. 1385, 708–717
1943.
6. I. M. Klotz, F. M. Walker, and R. B. Pivan, “The binding of organic
ions by proteins1,” J. Am. Chem. Soc. 688, 1486–1490 1946.
7. H. H. LeVeen and W. H. Fishman, “Combination of evans blue with
plasma protein: Its significance in capillary permeability studies,
blood dye disappearance curves, and its use as a protein tag,” Am. J.
Physiol. 1511, 26–33 1947.
8. S. Basu, J. A. Nagy, S. Pal, E. Vasile, I. A. Eckelhoefer, V. S. Bliss,
E. J. Manseau, P. S. Dasgupta, H. F. Dvorak, and D. Mukhopadhyay,
“The neurotransmitter dopamine inhibits angiogenesis induced byournal of Biomedical Optics 054049-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usevascular permeability factor/vascular endothelial growth factor,” Nat.
Med. 75, 569–574 2001.
29. W. Sluiter, L. W. M. Oomens, A. Brand, and R. Vanfurth, “Determi-
nation of blood-volume in the mouse with chromium-51-labeled
erythrocytes,” J. Immunol. Methods 731, 221–225 1984.
30. M. C. Pilatou, E. Marani, F. F. M. de Mul, and W. Steenbergen,
“Photoacoustic imaging of brain perfusion on albino rats by using
evans blue as contrast agent,” Arch. Physiol. Biochem. 1114, 389–
397 2003.
31. H. Sear, T. H. Allen, and M. I. Gregersen, “Simultaneous measure-
ment in dogs of plasma volume with i131 human albumin and t-1824
with comparisons of their long term disappearance from the plasma,”
Am. J. Physiol. 1752, 240–242 1953.
32. M. H. Wade, J. E. Trosko, and M. Schindler, “A fluorescence pho-
tobleaching assay of gap junction-mediated communication between
human cells,” Science 2324749, 525–528 1986.
33. P. W. Hamer, J. M. McGeachie, M. J. Davies, and M. D. Grounds,
“Evans blue dye as an in vivo marker of myofibre damage: optimising
parameters for detecting initial myofibre membrane permeability,” J.
Anat. 2001, 69–79 2002.
34. G. Thurston, C. Suri, K. Smith, J. McClain, T. N. Sato, G. D. Yan-
copoulos, and D. M. McDonald, “Leakage-resistant blood vessels in
mice transgenically overexpressing angiopoietin-1,” Science
2865449, 2511–2514 1999.
35. A. J. Thody and S. Shuster, “Control and function of sebaceous
glands,” Physiol. Rev. 692, 383–416 1989.September/October 2009  Vol. 1456
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
